Geode Capital Management, LLC Actinium Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 686,153 shares of ATNM stock, worth $885,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
686,153
Previous 666,310
2.98%
Holding current value
$885,137
Previous $4.93 Million
73.85%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ATNM
# of Institutions
74Shares Held
8.31MCall Options Held
65.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY1.88MShares$2.42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$2.1 Million0.0% of portfolio
-
State Street Corp Boston, MA603KShares$777,4170.0% of portfolio
-
Acadian Asset Management LLC Boston, MA454KShares$585,2650.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT359KShares$463,5650.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $32.5M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...